Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy

BACKGROUND: Currently, the optimal maintenance therapy for patients with acute promyelocytic leukemia (APL) who have achieved complete remission (CR) after completing consolidation chemotherapy remains controversial. The comparative effectiveness of the all-trans retinoic acid (ATRA) plus arsenic tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Bin, Zheng, Zhouyi, Shi, Yifen, Chen, Jingjing, Hu, Xudong, Qian, Honglan, Shen, Zhijian, Jiang, Songfu, Yu, Kang, Feng, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414635/
https://www.ncbi.nlm.nih.gov/pubmed/28490888
http://dx.doi.org/10.2147/OTT.S135013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414635/
https://www.ncbi.nlm.nih.gov/pubmed/28490888
http://dx.doi.org/10.2147/OTT.S135013

Ejemplares similares